Medicine and HealthNature Communications
ARF suppression by MYC but not MYCN confers increased malignancy of aggressive pediatric brain tumors
O. J. Mainwaring, H. Weishaupt, et al.
This groundbreaking research by Oliver J. Mainwaring and colleagues presents an innovative transgenic mouse model that mimics Group 3 medulloblastoma, revealing insights into MYC amplifications and ARF silencing. Their findings pave the way for targeted therapies, particularly highlighting the efficacy of the HSP90 inhibitor Onalespib against MYC-driven tumors. Discover the potential for advancing treatments in pediatric brain cancer!
Related Publications
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Psychology
Patterns of brain asymmetry associated with polygenic risks for autism and schizophrenia implicate language and executive functions but not brain masculinization
Z. Sha, D. Schijven, et al.
Medicine and Health
Molecular profiling of 888 pediatric tumors informs future precision trials and data-sharing initiatives in pediatric cancer
S. J. Forrest, H. Gupta, et al.
Health and Fitness
Perspectives of scholars on the origin, spread and consequences of COVID-19 are diverse but not polarized
P. K. Paudel, R. Bastola, et al.
Environmental Studies and Forestry
Linear infrastructure habitats increase landscape-scale diversity of plants but not of flower-visiting insects
J. Dániel-ferreira, R. Bommarco, et al.
